// App-Quantinova.ai

: Autologous Versus Haploidentical Stem Cell Transplantation in Adult Patients with Intermediate Risk Actue Myelogenous Leukemia in First Complete Remission and Undetectable Minimal Residual Disease: A Global Preliminary Analysis of Chinese Data

Researchers

Presenter

  • Jia Chen

Principal Investigators

  • Yiyang Ding

  • Xi Zhang

  • Erlie Jiang

  • Lin Liu

  • He Huang

  • Jiong Hu

  • Jishi Wang

  • Yanming Zhang

  • Myriam Labopin

  • Irma Khvedelidze

  • Emmanuelle Polge

  • Arnon Nagler

  • Mohamad Mohty

  • Depei Wu

  • Norbert Claude Gorin

Medical Centers

  • Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang City, China

  • on behalf of the global committee and the acute leukemia working party of the EBMT, Paris, China

  • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

  • The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China

  • EBMT Global Committee and Acute Leukemia Working Party, Hopital Saint-Antoine APHP and Sorbonne University, Paris, China

  • Department of Hematology, Xinqiao Hospital, The Third Military Medical University, Chongqing, China

  • Department of Hematology, Huai'an Second People's Hospital, Huai'an, China

  • The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

  • The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel

  • The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Locations

  • China

  • Israel

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Graft-versus-host disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Global

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A